Aldeyra Therapeutics Inc Stock Price (ALDX)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

Abeona Therapeutics (NASDAQ:ABEO) Stock Price Passes Above 50 Day Moving Average of $2.54Sat, 25 Mar 2023 03:46:48 UTC via ETF Daily News
Piper Sandler Lowers Tempest Therapeutics (NASDAQ:TPST) Price Target to $6.00Sat, 25 Mar 2023 03:46:42 UTC via ETF Daily News
Cara Therapeutics (NASDAQ:CARA) Stock Crosses Below Two Hundred Day Moving Average of $10.11Sat, 25 Mar 2023 03:26:47 UTC via ETF Daily News
HC Wainwright Comments on Context Therapeutics Inc.’s FY2027 Earnings (NASDAQ:CNTX)Sat, 25 Mar 2023 03:08:41 UTC via ETF Daily News
Equities Analysts Offer Predictions for Rani Therapeutics Holdings, Inc.’s Q1 2024 Earnings (NASDAQ:RANI)Sat, 25 Mar 2023 03:02:49 UTC via ETF Daily News
TCR2 Therapeutics (NASDAQ:TCRR) Stock Rating Reaffirmed by EF Hutton Acquisition Co. ISat, 25 Mar 2023 03:02:48 UTC via ETF Daily News
Acerus Pharmaceuticals (OTCMKTS:ASPCF) and Ovid Therapeutics (NASDAQ:OVID) Head-To-Head ContrastSat, 25 Mar 2023 02:38:43 UTC via ETF Daily News
Galectin Therapeutics (NASDAQ:GALT) Stock Price Passes Above 200-Day Moving Average of $1.48Sat, 25 Mar 2023 02:36:48 UTC via ETF Daily News
Dermata Therapeutics (NASDAQ:DRMA) Price Target Lowered to $4.00 at Maxim GroupSat, 25 Mar 2023 02:28:43 UTC via ETF Daily News
Rani Therapeutics (NASDAQ:RANI) Stock Rating Reaffirmed by HC WainwrightSat, 25 Mar 2023 02:26:50 UTC via ETF Daily News

Aldeyra Therapeutics Inc Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:ALDX

You don't have any alerts set for IEX:ALDX.

About Aldeyra Therapeutics Inc

Aldeyra Therapeutics Inc is biotechnology company focused on the development of products for inflammation, inborn errors of metabolism, and other diseases, related to endogenously generated toxic and pro-inflammatory chemical species known as aldehydes.

CEOTodd C. Brady IndustryBiotechnology SectorHealthcare Websitehttps://www.aldeyra.com Issue ExchangeNASDAQ Capital Market Issue TypeUnknown

Real-time ALDX to USD Trade Analysis on IEX

Market Status Closed

Analysis is available when the exchange & market are open.